Intravascular Ultrasound for Hepatocellular Carcinoma Staging
|ClinicalTrials.gov Identifier: NCT00474734|
Recruitment Status : Unknown
Verified May 2007 by University Hospital, Geneva.
Recruitment status was: Recruiting
First Posted : May 17, 2007
Last Update Posted : May 17, 2007
To diagnose hepatocellular carcinoma (HCC) and to determine the extent of the disease, a triphasic CT scan or a magnetic resonance imaging are required. The characterization of hepatic nodules is more difficult when the HCC lesions have a diameter of less than 2 cm.
Since accuracy in the assessment of the number and the size of HCC nodules, as well as of the invasion of blood vessels is crucial to determine outcome after liver transplantation due to tumour recurrence, there is a need for techniques with a higher definition potential.
As a consequence, to improve outcome and to optimize organ allocation, patients on the liver transplantation waiting list might benefit from intravascular ultrasound as an additional examination to complete the pre-transplant tumour staging process.
|Condition or disease||Intervention/treatment|
|Hepatocellular Carcinoma||Device: Intravascular ultrasound of the liver|
|Study Type :||Observational|
|Observational Model:||Defined Population|
|Official Title:||Intravascular Ultrasound for the Staging of Hepatocellular Carcinoma: a Pilot Study|
|Study Start Date :||May 2007|
|Estimated Study Completion Date :||September 2007|
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00474734
|Contact: Antoine Hadengue, Prof.||+41 22 37 29 email@example.com|
|University Hospital Geneva||Recruiting|
|Contact: Andrea De Gottardi, MD PhD +41 22 37 29 256 firstname.lastname@example.org|
|Study Chair:||Antoine Hadengue, Prof.||University Hospital, Geneva|